CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and ...
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias
The healthcare company said Chair Lina Khan, Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya through ...
CVS, UnitedHealth, Cigna say FTC should take Lina Khan and two commissioners off drug middlemen case
The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" ...
UnitedHealth, CVS, Cigna accuse FTC Chair Khan of 'serious bias' against PBMs
UnitedHealth Group and CVS Health are asking FTC commissioners to recuse themselves from a case against pharmacy benefit ...
CVS, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit
UnitedHealth and CVS Caremark are calling on a federal judge to disqualify Federal Trade Commission (FTC) Chair Lina Khan and ...
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that ...
CVS and UnitedHealth want FTC Chair Lina Khan to recuse herself from a case over insulin prices
CVS (CVS) and UnitedHealth Group (UNH) on Tuesday demanded that Federal Trade Commission (FTC) Chair Lina Khan and two other ...
Modern Healthcare9h
CVS, UnitedHealth seek FTC recusal over bias in insulin case
The FTC has accused units of CVS, Cigna and UnitedHealth of unfair trade practices in how they managed insulin prescriptions.
STAT11h
Major PBMs ask judge to remove Lina Khan from FTC’s insulin-price lawsuit
UnitedHealth Group and CVS Health have petitioned a judge to sideline FTC Chair Lina Khan from the agency’s lawsuit against ...
Healthcare Firms Call FTC’s Khan Biased. They Want Her Off the Insulin Case.
The agency has filed an administrative complaint accusing pharmacy benefit managers of artificially inflating the price of ...
CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan
Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week.
A free drug experiment bypasses the US health system's secret fees
A top California health plan is set to offer one of the world's biggest-selling drugs for free in a bid to show the medicine ...